We first analyze the association between DJ-1 expressions and TNM stages in serum and tissue pairs of colorectal tumor tissues and adjacent normal tissues from patients to determine whether DJ-1 could serve as a serum biomarker in colorectal cancer. This evidence concerns the gene PARK7 and colorectal cancer.